Science | ABNewswire

From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)

Artificial intelligence is moving beyond broad models and experimental tools. It is increasingly being applied to specific problems in defined industries where it can create measurable value. This includes sectors such as healthcare, enterprise software, defense, and industrial automation. The … Continue reading →

Von Willebrand Disease Market Outlook to 2034: Expanded FDA Approval of Takeda’s VONVENDI Strengthens Treatment Landscape | DelveInsight

Von Willebrand Disease Market Outlook DelveInsight’s latest report, “Von Willebrand Disease (VWD) – Market Insight, Epidemiology, and Market Forecast – 2034,” highlights how evolving therapies, regulatory milestones, and competition are shaping the VWD market across the 7MM (the US, EU4, … Continue reading →

Microsatellite Stable Colorectal Cancer Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, DelveInsight

DelveInsight’s “Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast- 2032” report delivers an in-depth understanding of the Microsatellite Stable Colorectal Cancer, historical and forecasted epidemiology as well as the Microsatellite Stable Colorectal Cancer market trends in the United … Continue reading →

C-MET NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s “C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the C-MET Non-Small Cell Lung Cancer pipeline landscape. It covers the C-MET+ NSCLC pipeline drug profiles, including … Continue reading →

PD-1+ NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) pipeline landscape. It covers the pipeline drug profiles, including clinical … Continue reading →

EGFR + NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the EGFR + NSCLC … Continue reading →

Metastatic Pancreatic Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Metastatic Pancreatic Cancer Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It covers the Metastatic Pancreatic Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →

Pancreatic Ductal Adenocarcinoma Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Pancreatic Ductal Adenocarcinoma Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It covers the Pancreatic Ductal Adenocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Advanced Recurrent Ovarian Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Advanced Recurrent Ovarian Cancer Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Advanced Recurrent Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

HER2 Positive Gastric Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “HER2 Positive Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HER2 Positive Gastric Cancer pipeline landscape. It covers the HER2 Positive Gastric Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Monday - April 20, 2026

Category Archives: Science